Onset of action of the beta 3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder

Christopher R. Chapple; Victor W. Nitti; Vik Khullar; Jean Jacques Wyndaele; Sender Herschorn; Philip van Kerrebroeck; Mary Beth Blauwet; Emad Siddiqui

doi:10.1007/s00345-014-1244-2

Onset of action of the beta 3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder

Christopher R. Chapple, Victor W. Nitti, Vik Khullar, Jean Jacques Wyndaele, Sender Herschorn, Philip van Kerrebroeck, Mary Beth Blauwet, Emad Siddiqui

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1565-1572
Journal	World Journal of Urology
Volume	32
Issue number	6
DOIs	https://doi.org/10.1007/s00345-014-1244-2
Publication status	Published - Dec 2014

Keywords

Mirabegron
Overactive bladder
beta(3)-Adrenoceptor agonist
Onset of action

Access to Document

10.1007/s00345-014-1244-2

Cite this

Chapple, C. R., Nitti, V. W., Khullar, V., Wyndaele, J. J., Herschorn, S., van Kerrebroeck, P., Blauwet, M. B., & Siddiqui, E. (2014). Onset of action of the beta 3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder. World Journal of Urology, 32(6), 1565-1572. https://doi.org/10.1007/s00345-014-1244-2

Chapple, Christopher R. ; Nitti, Victor W. ; Khullar, Vik ; Wyndaele, Jean Jacques ; Herschorn, Sender ; van Kerrebroeck, Philip ; Blauwet, Mary Beth ; Siddiqui, Emad. / Onset of action of the beta 3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder. In: World Journal of Urology. 2014 ; Vol. 32, No. 6. pp. 1565-1572.

@article{4a1592a708fb4984bc4040b7d5f2d5aa,

title = "Onset of action of the beta 3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder",

keywords = "Mirabegron, Overactive bladder, beta(3)-Adrenoceptor agonist, Onset of action",

author = "Chapple, {Christopher R.} and Nitti, {Victor W.} and Vik Khullar and Wyndaele, {Jean Jacques} and Sender Herschorn and {van Kerrebroeck}, Philip and Blauwet, {Mary Beth} and Emad Siddiqui",

year = "2014",

month = dec,

doi = "10.1007/s00345-014-1244-2",

language = "English",

volume = "32",

pages = "1565--1572",

journal = "World Journal of Urology",

issn = "0724-4983",

publisher = "Springer, Cham",

number = "6",

}

Onset of action of the beta 3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder. / Chapple, Christopher R.; Nitti, Victor W.; Khullar, Vik; Wyndaele, Jean Jacques; Herschorn, Sender; van Kerrebroeck, Philip; Blauwet, Mary Beth; Siddiqui, Emad.

In: World Journal of Urology, Vol. 32, No. 6, 12.2014, p. 1565-1572.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Onset of action of the beta 3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder

AU - Chapple, Christopher R.

AU - Nitti, Victor W.

AU - Khullar, Vik

AU - Wyndaele, Jean Jacques

AU - Herschorn, Sender

AU - van Kerrebroeck, Philip

AU - Blauwet, Mary Beth

AU - Siddiqui, Emad

PY - 2014/12

Y1 - 2014/12

KW - Mirabegron

KW - Overactive bladder

KW - beta(3)-Adrenoceptor agonist

KW - Onset of action

U2 - 10.1007/s00345-014-1244-2

DO - 10.1007/s00345-014-1244-2

M3 - Article

VL - 32

SP - 1565

EP - 1572

JO - World Journal of Urology

JF - World Journal of Urology

SN - 0724-4983

IS - 6

ER -